Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01936922 · ClinicalTrials.gov registry record · Phase 1
Testing Whether Brief Use of a Virtual Reality Device Improves Gait
A Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01936922 is a Phase 1 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants.
The verdict
NCT01936922, a Phase 1 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
A virtual reality device has already been successfully used for improving gait in adults who have neurological conditions. We will evaluate if it is feasible to study the brief use of this device in older adults who have had falls.
Interventions
- DEVICE GaitAid®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01936922
The ClinicalTrials.gov registry entry for NCT01936922 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GaitAid® is the first listed.
NCT01936922 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01936922 about?
NCT01936922 is a clinical study titled "Testing Whether Brief Use of a Virtual Reality Device Improves Gait". A virtual reality device has already been successfully used for improving gait in adults who have neurological conditions. We will evaluate if it is feasible to study the brief use of this device in older adults who have had falls.
What is the current status of trial NCT01936922?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2013-09. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01936922?
The interventions under investigation include: GaitAid® (DEVICE).
Who is sponsoring clinical trial NCT01936922?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.